[DOI] [PMC free article] [PubMed] [Google Scholar] 11.Brown E., Heerspink H.J.L., Cuthbertson D.J., Wilding J.P.H
Trusted for over 90 years.
Why we do not build brain-health care around microdosing claims The most concerning part of the microdosing narrative is not that some patients do well on lower doses
It is also worth considering that fatigue attributed to GLP-1 therapy may actually reflect underlying conditions such as hypothyroidism, anemia, sleep apnea, or depression, which should be evaluated if tiredness persists
Customized plans with food logging, water tracking, and movement options for all fitness levels
doi: 10.3390/biom13091332 Summary Keywords GLP-1 receptor agonists, Sepsis, muscle atrophy, inflammation, oxidative stress Citation Dimic N, Djuric M, Vejapi M, Nenadic I, Bobos M, Bojic S, Savic P, Milanovic M and Stevanovic P (2025) The role of GLP-1 in the pathophysiology and treatment of sepsis: a narrative review